The joint patent application by Hacettepe University and Başkent University, titled “Magnetic Nanoparticle Stimulation Device,” was awarded a Bronze Medal at the TÜRKPATENT ISIF’25 – Istanbul International Invention Fair, held in Istanbul between 17–21 September 2025. The invention, whose examination process is ongoing under the patent application number 2024/006944, was developed for the controlled stimulation of magnetic nanoparticles and for hyperthermia treatment in biomedical applications.
Developed by researchers from Hacettepe University and Başkent University, the “Magnetic Nanoparticle Stimulation Device” was presented with a certificate of achievement by officials of the Turkish Patent and Trademark Office during the fair held at Istanbul Atatürk Airport between 17–21 September 2025 as part of this year’s TEKNOFEST.
The patent application for the invention was submitted to the Turkish Patent and Trademark Office under the title “Magnetic Nanoparticle Stimulation Device” with the application number 2024/006944, and the examination process is ongoing. The applicants are Hacettepe University and Başkent University, while the inventors are Prof. Dr. İsmail Cengiz Koçum, Prof. Dr. Yeşim Sağ Açıkel, and Dr. Görkem Polat.
The Magnetic Nanoparticle Stimulation Device consists of a specialized circuit designed to provide controlled stimulation of magnetic nanoparticles in biomedical applications and a magnetic field stimulation system that incorporates this circuit. Thanks to its adjustable magnetic field strength and frequency, the device aims to offer a flexible and relatively low-cost solution that can be used both in drug release studies triggered by magnetic fields and in magnetic hyperthermia applications employed in cancer treatment.
The award-winning researchers expressed their thoughts as follows:
“This award enhances the visibility of the innovative medical devices and treatment approaches developed through the interdisciplinary collaboration of our universities on national and international platforms, while also providing important motivation for the commercialization and future clinical application steps of the patent application in question.”